Panel Discussion: Engaging Different Stakeholders to Maximise Early Access Programme Success

Time: 1:45 pm
day: Day One


  • Overcome internal resistance to early access programmes by enhancing stakeholders’ understanding of the protection pharmaceutical companies are granted by European regulations
  • Discussing strategies to convey the value proposition and benefits of EAPs to stakeholders
  • Educating key stakeholders on the strengths and limitations of early access programmes